146 related articles for article (PubMed ID: 9793260)
1. Nail changes after chemotherapy.
Las Heras G; Juncà Piera J
Haematologica; 1998 Aug; 83(8):748. PubMed ID: 9793260
[No Abstract] [Full Text] [Related]
2. A case of hydroxyurea-induced longitudinal melanonychia.
Utaş S; Kulluk P
Int J Dermatol; 2010 Apr; 49(4):469-70. PubMed ID: 20465711
[No Abstract] [Full Text] [Related]
3. Hydroxyurea in sickle cell disease.
Adams-Graves P; Heltsley C; Deitcher S
N Engl J Med; 1996 Feb; 334(5):333-4. PubMed ID: 8532043
[No Abstract] [Full Text] [Related]
4. Nail changes in a patient with leukaemia.
Bhaskar ME
BMJ; 2011 Jan; 342():c6439. PubMed ID: 21224311
[No Abstract] [Full Text] [Related]
5. Longitudinal melanonychia associated with hydroxyurea therapy in a patient with essential thrombocytosis.
Cohen AD; Hallel-Halevy D; Hatskelzon L; Peretz E; Halevy S
J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):137-9. PubMed ID: 10568495
[TBL] [Abstract][Full Text] [Related]
6. Images in clinical medicine. Acquired melanonychia.
Ranta D; Bonmati C
N Engl J Med; 2009 Sep; 361(12):1188. PubMed ID: 19759381
[No Abstract] [Full Text] [Related]
7. Mucocutaneous lesions and nail pigmentation in a patient with essential thrombocytosis.
Calleja Algarra A; Miguel RA; Tous Romero F; Maroñas Jiménez L
Aust Fam Physician; 2017; 46(4):222-224. PubMed ID: 28376576
[No Abstract] [Full Text] [Related]
8. Primary thrombocythemia: new drugs for an evolving disease.
Balduini CL
Haematologica; 1992; 77(4):297-301. PubMed ID: 1427439
[No Abstract] [Full Text] [Related]
9. Hydroxyurea-Induced Oral Hyperpigmentation: A Case Report and Review of the Literature.
Veillet-Lemay G; Haber RM
J Cutan Med Surg; 2019; 23(1):111-113. PubMed ID: 30232899
[No Abstract] [Full Text] [Related]
10. [Acute myeloid leukemia developing in the course of essential thrombocythemia].
Fernández MC; Gardelegui I; Capote FJ; Gil JL; Muñoz JA
Sangre (Barc); 1996 Oct; 41(5):405-6. PubMed ID: 9026932
[No Abstract] [Full Text] [Related]
11. Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practice.
Reilly JT
Eur J Haematol Suppl; 2007 Oct; (68):32-4. PubMed ID: 17727564
[No Abstract] [Full Text] [Related]
12. Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia.
Dingli D; Tefferi A
Curr Hematol Malig Rep; 2006 Jun; 1(2):69-74. PubMed ID: 20425334
[TBL] [Abstract][Full Text] [Related]
13. Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution.
Radaelli F; Onida F; Rossi FG; Zilioli VR; Colombi M; Usardi P; Calori R; Zanella A
Hematology; 2008 Aug; 13(4):195-202. PubMed ID: 18796244
[TBL] [Abstract][Full Text] [Related]
14. Melanonychia.
Charan S; Mishra K; Jandial A; Khadwal A; Malhotra P
QJM; 2018 Dec; 111(12):909. PubMed ID: 29986101
[No Abstract] [Full Text] [Related]
15. Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Barbui T; Barosi G; Grossi A; Gugliotta L; Liberato LN; Marchetti M; Mazzucconi MG; Rodeghiero F; Tura S
Haematologica; 2004 Feb; 89(2):215-32. PubMed ID: 15003898
[TBL] [Abstract][Full Text] [Related]
16. Melanonychia and mucocutaneous hyperpigmentation due to hydroxyurea use in an HIV-infected patient.
Laughon SK; Shinn LL; Nunley JR
Int J Dermatol; 2000 Dec; 39(12):928-31. PubMed ID: 11168664
[No Abstract] [Full Text] [Related]
17. Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug.
Passamonti F; Cazzola M
Haematologica; 2004 Nov; 89(11):1284. PubMed ID: 15531447
[No Abstract] [Full Text] [Related]
18. [Hyperalgesic malleolar ulcer: recovery on the withdrawal of hydroxyurea].
Liebschutz S; Quéré I; Lukasik E; Dereure O; Rondes J; Janbon C
Rev Med Interne; 1998 May; 19(5):360-1. PubMed ID: 9775174
[No Abstract] [Full Text] [Related]
19. Toenails melanonychia induced by hydroxyurea.
Kluger N; Naud M; Françès P
Presse Med; 2012 Apr; 41(4):444-5. PubMed ID: 21996473
[No Abstract] [Full Text] [Related]
20. [What vascular events suggest a myeloproliferative disorder?].
Hachulla E; Rose C; Trillot N; Caulier-Leleu MT; Pasturel-Michon U
J Mal Vasc; 2000 Dec; 25(5):382-387. PubMed ID: 11148402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
